chrisvoncsefalvay/vaers-outcomes huggingface dataset:
wasn't up to par; chills; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (wasn't up to par), CHILLS (chills) and HEADACHE (bad headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (She was hospitalized until February.She had some blood clots during the COVID-19 hospitalization. She still had a cough and used oxygen.) in December 2020. Concurrent medical conditions included Cough.    On 15-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-May-2021, the patient experienced CHILLS (chills) and HEADACHE (bad headache). On 17-May-2021, the patient experienced MALAISE (wasn't up to par). The patient was treated with PARACETAMOL (TYLENOL) on 16-May-2021 for Chills and Headache, at a dose of UNK, one time dose. On 17-May-2021, CHILLS (chills) and HEADACHE (bad headache) had resolved. At the time of the report, MALAISE (wasn't up to par) was resolving.            On 18-May-2021, the patient felt better. She made her breakfast by herself. Concomitant medications were not provided.   This case was linked to MOD-2021-142645 (Patient Link).
Patient reported on Nov 12, 2018 that he has been having a debilitating pain in the left arm ever since he got the flu shot on Sept 17, 2018. He is going to have MRI. Patient reported also having adverse reaction in the past with the flu shot but this one took longer.
WARMTH, REDNESS, AND SWELLING AT INJECTION SITE AND DOWN ENTIRETY OF LEFT ARM BEGINNING 07/30/2019 AND WORSENING. PATIENT ADVISED TO ICE ARM, KEEP ELEVATED, AND TO TAKE BENADRYL.
Woke up in the morning with soreness in wrist and elbow and practically zero use of my left hand.  Woke up on left side so just assumed hand was asleep.  After 15 minutes of no improvement,  I started to panic thinking I was having a stroke.   Realizing I had no other symptoms and was feeling fine otherwise I knew that likely wasn't the case. Besides having zero strength (I did have feeling) my hand would curl inward toward my body.  I could manipulate with my right hand by it would always curl back in. I was barely able to grip, would actually have to manipulate my fingers into a grasp, couldn't do it on it's own, and holding something as light as my cellphone would cause my hand to turn down towards the floor. Pain level I would only describe as soreness in my wrist and elbow.  Annoying but not painful. It's now over 24 hours since symptoms first appeared and besides some slight weakness in the hand I would say I'm 95% better.
4PM day p/MMR, pt exp hives on rt elbow; quickly progressed to giant hives, itching, swelling & joint pain; ER md inj DPH & prescribed Pred tablets x 4 days;
c/o nasal congestion on 18OCT that proceeded to chest congestion w/productive cough over the next couple of days;chest pain started on 25OCT95 & has been intermittent since taking NTG w/some relief
3 blocked veins/blood clots going from his liver to his heart and from his intestines to his liver; diarrhea every 15min; getting stomach cramps/pain in his stomach; This is a spontaneous report received from a non-contactable reporter (Consumer) from medical information team. The reporter is the parent (father).  An adult (reported 28-29 years old) male patient received BNT162b2 as dose 2, single (Batch/Lot number: unknown) (reported as over one year ago) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 immunization. The following information was reported: EMBOLISM VENOUS (medically significant), outcome " Not recovered/Not resolved", described as "3 blocked veins/blood clots going from his liver to his heart and from his intestines to his liver"; DIARRHOEA (medically significant), outcome "unknown", described as "diarrhea every 15min"; ABDOMINAL PAIN UPPER (non-serious), outcome "unknown", described as "getting stomach cramps/pain in his stomach". Months later the patient started getting stomach cramps, diarrhea and kind of messed up. 3-4 months afterwards he started developing pain in his stomach and was having diarrhea every 15 minutes. He was diagnosed with 3 blocked veins, one going from liver to heart, another from intestines to liver, and one other one. The events "diarrhea every 15min" and "getting stomach cramps/pain in his stomach" required physician office visit. The events "3 blocked veins/blood clots going from his liver to his heart and from his intestines to his liver" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Ultrasound scan: diagnosed with 3 blocked veins, notes: one going from liver to heart, another from intestines to liver, and one other one. Therapeutic measures were taken as a result of embolism venous. The patient has been taking blood thinners Xarelto to get rid of the blood clots. Two of the veins were open now but one vein was 100% blocked and had been for 6 months.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
54 y o female c/o hives to face _ none seen) , lip tingling and 5/10  chest pain   Given 50 mg of Benadryl IM right deltoid at 204 pm  and placed on 10 lpm O2 via mask at 205 pm  O2 reduced to 8 lpm via mask after 2/10 chest pain Lungs CTA bilaterally non-labored breathing.  Client had used albuterol PTA  Client on room air at 234 pm and feeling good.  Denies any lip tingling  Chest pain resolved.  VSS 102/78 70 24   Client agreed to follow up with PCP prior to 2nd CoVid vaccine.     Meds:  Zyrtex, albuterol, Advair, Flonase, singular  Allergies:  morphine, lidocaine, EES Client DC;d home stable NAD MAEW non-labored breathing
I got diagnosed with Cellulitis at the injection site on my left arm. Arm was swollen, inflamed, tender/sore, extremely hot to touch, and itchiness. Prescribed Sulfameth/Trimethoprim 800/160MG TB. The one pill twice a day for 7 days. Most of symptoms have gone away except for a tender/hard lump and itchiness.
This case was reported by a consumer and described the occurrence of upset stomach in a 4 hour-old male subject who was vaccinated with BOOSTRIX, (GlaxoSmithKline).  A physician or other health care professional has not verified this report.  On 17 September 2009 at 15:45 the subject inadvertently received a dose of BOOSTRIX at 0.5 ml in the right thigh.  On 17 September 2009, at an unspecified time after vaccination with BOOSTRIX, the subject experienced upset stomach and gassiness.  This was also a maladministration (asymptomatic/child too young).  At the time of reporting the events of upset stomach and gassiness were unresolved.
Tinnitus, hearing acuity decreased rt. ear, headache, nausea, vertigo, fatigue until shot #2, then symptoms worsened and still persist.
No symptoms was reported by the patient at the time of the appointment. MA working with Provider gave an expired Moderna that was drawn at 4pm 03/03/2022 thrusday.
7-30-2010 Fever 99.4 - Erythemic face. Fine rash to neck, upper chest, upper back. Lighter rash to upper arms. Patients father brought child in to have rash checked.
PATIENT CAME BACK ON 10/25/17 (LATE AFTERNOON) TO SHOW THE REACTIONS SHE EXPERIENCED. THE INJECTION SITE WAS RED, SWELLING, AND PT INFORMED THE AREA FELT WARM. THE AFFECTED AREA WAS ABOUT 2.5 IN LENGTH AND 3.5 INCHES IN WIDTH. I ADVISED PT TO USE ICE-PACK IN THE AREA, TAKE BENADRYL FOR SWELLING, AND TO CONTACT THE PRIMARY DR. IF SYMPTOMS GET WORSE. ALSO, ADVISED PT TO GO TO EMERGENCY ROOM IF THERE IS ANY DIFFICULTY IN BREATHING. ON 10/26/17 PT RETURNED AND THE INSPECTION WAS DONE BY PHARMACIST MANAGER. THE PHARMACIST NOTED THE DIAMETER WAS ABOUT 4-5 INCHES, AND THE PT SEEMED COMFORTABLE WITH NO COMPLAINT OF OTHER SYMPTOMS. A PHONE FOLLOW UP WAS DONE ON 10/28/17. PT INFORMED THAT SHE TOOK ONE BENADRYL 25MG TO RELIEVE ITCHINESS ON ARM AT BEDTIME ON 10/27/17. PT SAID THE SWELLING AND REDNESS HAS DECREASED SUBSTANTIALLY.
Swollen, red left thigh 7-8cm in size.  Tylenol, cold compress, Benadryl.
ACHINESS; ADMINISTERED VACCINE 7.5 HOURS AFTER PUNCTURE; FEVER; TIREDNESS; This spontaneous report received from a pharmacist concerned a 34 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855835 expiry: UNKNOWN) dose was not reported, administered on 06-DEC-2021 17:00 for prophylactic vaccination (dose number in series 1). No concomitant medications were reported. On 06-DEC-2021, the patient experienced achiness. On 06-DEC-2021, the patient experienced administered vaccine 7.5 hours after puncture. On 06-DEC-2021, the patient experienced fever. On 06-DEC-2021, the patient experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administered vaccine 7.5 hours after puncture, fever, tiredness and achiness was not reported. This report was non-serious.
First dose was taken on 3 April 2021; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was taken on 3 April 2021) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was taken on 3 April 2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was taken on 3 April 2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
0.5 ml of COVID pfizer vaccine given instead of 0.3 ml.  No treatment necessary, no advers effects.  CDC was called for guidance.
Systemic: Allergic: Anaphylaxis-Mild, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Shakiness-Medium
Patient 12 weeks pregnant presents to ER with sore throat, fever (99.5) and vomiting of blood.
This spontaneous report as received from a medical assistant refers to a 2-year-old patient of unknown gender. No concurrent conditions, medical history, concomitant medications and drug allergies were reported. On 19-JUN-2015, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) (lot # K021484 and expiry date on 03-NOV-2016; dose and route not reported). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Loss of blood found to be from small intestine; Cardiac arrest; Going into shock; Rash all over face; Hemoglobin low; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9810), via an unspecified route of administration (right deltoid) on 05Feb2021 (at the age of 70 years old) as single dose for Covid-19 immunization. The patient's medical history included hypertension (ongoing), COPD (chronic obstructive pulmonary disease) (ongoing), arthritis (ongoing), cholesterol (abnormal), and pain. Concomitant medications in two weeks included atorvastatin 40 mg for cholesterol (abnormal), gabapentin 300 mg for pain, amlodipine 5 mg for blood pressure (abnormal), losartan 100 mg for high blood pressure, aspirin [acetylsalicylic acid] 81 mg for unspecified indication, potassium for unspecified indication, and meloxicam 15mg for arthritis; start and stop date not reported for all. The patient previously took Tylenol and Codeine and experienced allergies on both. No other vaccine was received in four weeks. The patient experienced rash all over face, loss of blood found to be from small intestine, hemoglobin low, cardiac arrest, going into shock on 05Feb2021. Events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient was hospitalized for 6 days due to above events. Covid test post vaccination included Nasal swab with Negative result on 11Mar2021. Treatment included blood transfusion. The patient further reported that the rash on face on 05Feb2021 (Onset Time (24hr): early evening) was not serious; it required visit to physician office, appointment for dermatologist, treatment is unknown and is recovering. The outcome of event rash was recovering; the outcome of other events was not recovered.  Information about lot/batch number has been requested.  Follow-up (08Apr2021): This follow-up is being submitted to notify that the batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.  Follow-up (14Apr2021, 19Apr2021, 20Apr2021): New information reported from the same contactable consumer included: suspect drug details, medical history, concomitant medication, reporter information (patient), and event information.  No follow-up attempts are possible. No further information is expected. Information on lot number already obtained.
Information has been received from a published article, title as stated above. This literature case was initially reported on 29-MAR-2010. This article concerned 32 patient's (8 male and 24 female) aged between one to 57 years (mean age of patients was 29 years). The patients received a RECOMBIVAX HB, manufacturer, batch number, route and site not reported, on unreported dates. This report concerns patient #16 of 32, a 29 year old female. On an unreported date between 1982 and 2009, one to fifteen days post vaccination, the patient experienced uveitis (mean time to onset of three days). The uveitis was reported to occur after the first vaccination in 15 patients, after the second vaccination in three patients and after the third vaccination in three patients. The duration of the uveitis was not reported for nine patients. One patient had recurrent uveitis after the first and second doses of vaccine. One patient had recurrent uveitis after both the second and third doses. Patient outcome had not been reported. A 29 year old female on an unspecified date was vaccinated with a dose of RECOMBIVAX HB (lot number, route and site not reported). Concomitant therapy included typhoid vaccine (unspecified). One day after vaccination, the patient developed uveitis. At the time of the report, the patient's outcome was not reported. The patient also experienced symptoms of arthralgia, erythema nodosum, elevated sedimentation rate and fever. The authors stated the RECOMBIVAX HB may have a possible association with the development of uveitis in some patients. Immune complex deposition and adjuvant effects are potential pathogenic mechanisms. Uveitis was considered to be an other important medical event. Other business partner numbers include E2010-02312. Additional information has been requested. The article also discussed the experience of an additional 31 patients while on therapy with RECOMBIVAX HB (WAES #1004USA01716, WAES # 1004USA02327 to WAES # 1004USA02340, WAES # 1004USA02342 to WAES # 1004USA02357). A copy of the published article is attached as further documentation of the patient's experience.
Pneumova was supposed to be given one year after Prevnar 13 but was not given; This spontaneous report was received from a pharmacist via Pfizer concerning an elderly female patient who was currently 77-year-old. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unspecified date in 2014 (reported as five years ago) the patient had previously administered with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, route, lot# and expiry date were unknown) and there was gap and then on an unknown date in February 2015, she got pneumococcal 13v conj vaccine (CRM197) (PREVENAR 13) (dose, route, lot# and expiry date were unknown) and was reported that pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was supposed be given one year later and was not given (inappropriate schedule of product administration) and was enquiring if the series to be re-started and wanted to know which to be given.
This case was reported by a healthcare professional and described the occurrence of nausea in a female subject of unspecified age who was vaccinated with FLULAVAL (GlaxoSmithKline). On 28 November 2008, the subject received a dose of FLULAVAL (.5 unknown, unknown). On 28 November 2008, 4 hours after vaccination with FLULAVAL, the subject experienced nausea and diarrhea. The healthcare professional reported that a female subject received a FLULAVAL vaccination on 28 November 2008 and within four hours after the vaccination, she developed nausea and diarrhea. The healthcare professional stated that she was doing better and no further adverse events were reported. The healthcare professional refused to provide any details. At the time of reporting the events were resolved.
Red spot on the underside of my upper arm, above my elbow; a little bit of itching/The worst itching; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red spot on the underside of my upper arm, above my elbow) and PRURITUS (a little bit of itching/The worst itching) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced ERYTHEMA (Red spot on the underside of my upper arm, above my elbow) and PRURITUS (a little bit of itching/The worst itching). At the time of the report, ERYTHEMA (Red spot on the underside of my upper arm, above my elbow) and PRURITUS (a little bit of itching/The worst itching) outcome was unknown.            No relevant concomitant medication was reported.  Treatment information was not provided.
pain in arm and shoulder.  unable to move or use arm for 4 complete days.  Day 5 some movement, but still cannot lift arm up.  This has happened before, but I thought that it was just in the mussel, but I have felt bad these last 5 days.  feeling better today, but still having trouble with the arm. just taking over the counter meds.
Immediately after vaccines started to cough, wheeze - got hives. 9/8/09 Hospital records received DOS 8/20/09 to 8/21/09. Assessment: Anaphylactic reaction after immunization.  Patient developed anaphylactic reaction and presents with multiple hives on face, upper extremities, trunk. Wheezes, cough, mild distress. Generalized urticaria. Bronchospasm.
Anaphylactic like reaction, recorded on order per RX swelling of face, mouth, tongue. Solu-Medrol 50 mg, Benadryl 50mg IV, albuterol and ranitidine 50mg IV used for treatment.
Swelling tender-redness; over the rt upper arm; laterally 10cm/9cm;  shoulders movement;
numbness (same side as injection)  to her cheek, jaw, and side of throat that resolved the same day; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), on 03Feb2021 (at the age of 75-years-old) at 1st dose, single for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 03Feb2021, the patient experienced numbness (same side as injection) to her cheek, jaw, and side of throat that resolved the same day. The event was reported as non-serious. The patient was calling to ask if she should get the second dose. Her medical doctor (MD) was recommending that she not receive it. The patient had recovered from the event on 03Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
7/14 high fever began at 2:00pm of 102.5. Treated with alternating tylenol and motrin per dr. instruction. Fever lasted until 7/16. On 7/18 hives began all over her body. Two welts on lower calf, also one on face near eye. Noticed around 11:00am upon returning from outside. Took her to see Dr same day at 3:00pm.. Dr advised to treat with 5 ml of Zyrtec daily.
Narrative:  Pt presented to ED on 8/11/2022 wit cough and congestion x 1 week (approx. 8/4/22). Pt c/o LBP and left hip pain. Pt states he was walking x 1wk ago, then got this cold and can no longer walk. Pt admitted 8/11/22 - 8/26/22 with principal diagnosis = sepsis d/t serrati infection. ADDITIONAL DIAGNOSES: covid 19 infection alcohol use and dependence nicotine use and dependence hyponatremia hypomagnesia hypertension hiatel hernia alcoholic hepatitis iron deficient anemia HISTORY OF PRESENT ILLNESS: Patient is a 63 year old male with history of HTN/Alcohol dependence/GERD who was brought in by his sister due to cough for the past week not relieved by OTC and associated with generalized weakness. He was evaluated in ER and noted to have RLL pneumonia; he was covered with Rocephin and Zitho pending covid testing results; his covid was positive so medical services were contacted for further evaluation and treatment. Upon arrival to ER, patient is in respiratory isolation; he continues to c/o of cough which is productive of clear sputum; he denies fever, chills, hemoptysis, SOB or pleuritic pain; he admits to vomiting due to cough but denies nausea or diarrhea. HOSPITAL COURSE: Pt admitted to SDU. dx RLL pneumonia-with +covid. started on remdesivir for 3 days. cont CAP coverage with Rocephin and zithromax. no oxygen required. noted hx of etoh use - on ciwa protocol. hx of nicotine use - patch placed. corrected electrolytes as appropriate. day 2 dx changed to Gram negative sepsis. etiology unclear. checked ua/uc. CT abd/pelvis - ? gallbladder. adjust antibiotics to cefepime. bc result - serratia. ID consulted. MRI abd/pelvis and lumbar spine ordered -neg for acute process. pt stable for transfer to the floor on 8/13. cont antibiotics. per ID Serratia bacteremia with unclear source, pneumonia or GI most likely. continue cefepime 2g IV q8h for Serratia BSI. 14d course. prolonged QTc, so no oral options available. oncology consulted for anemia. noted abnormal +M-spike. immunofixation ordered but not resulted at discharge. plan for oncology follow up. initially plan was for STR. PT had done evaluation and recommended this. however, after a few days, the patient declined STR. Sister unable to take care of pt at this time due to also being COVID positive. Pt determined not to be candidate for home iv antibiotics. pt completed antibiotics as inpt. pt would decline PT services. pt tolerated medications. pt stable for d/c to home on 8/26/22